HOME >> MEDICINE >> NEWS
Walking Or Bed Rest OK For First Stage Of Labor, UT Southwestern Research Shows

DALLAS -- July 9, 1998 -- In the largest study of its kind, UT Southwestern Medical Center at Dallas obstetrics and gynecology researchers have concluded that walking during the first stage of labor is neither harmful nor beneficial to the mother or baby.

Dr. Steven Bloom, assistant professor of obstetrics and gynecology and lead author of the study published in today's New England Journal of Medicine, said women should be allowed to either walk or remain in bed during the first stage of labor, whichever is most comfortable to them. Current obstetrics practice dictates that a woman lie down during labor, but, as many doctors know, patients sometimes want to walk around, hoping to find comfort in motion.

Bloom and his colleagues assigned 1,067 women at Parkland Memorial Hospital in Dallas in spontaneous labor with uncomplicated pregnancies between 36 and 41 weeks' gestation to either a walking group or a bed-rest group. Seventy-eight percent of those assigned to the walking group actually walked; the rest had quicker labors, which may have precluded them from walking. Those in the bed-rest group were allowed to sit up. The researchers compared such factors as duration of the first stage of labor, the need for labor augmentation with medication, the use of analgesia for pain and the percentages of forceps deliveries and Caesarean sections.

"Labor and delivery outcomes were unrelated to walking, and infants' outcomes were also similar in the two study groups," Bloom concluded. "Walking neither enhanced nor impaired active labor and was not harmful to the mothers or their infants. Most of those who did walk indicated that they would do so again in a future labor. Since our results provide no objective evidence for or against walking during labor, it seems reasonable to let women elect either alternative."

This study brings the debate of walking or bed rest full circle since the first of the century. Bloom explained
'"/>

Contact: Ann Harrell
ann.harrell@email.swmed.edu
(214) 648-3404
UT Southwestern Medical Center
9-Jul-1998


Page: 1 2

Related medicine news :

1. Walking markedly improves mental abilities of those over 60
2. Walking cuts risk of heart attack in elderly men
3. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
4. First UK cases of previously rare disease reported in gay men
5. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
6. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
7. First US kidney cancer vaccine trial underway at Columbia
8. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
9. First blood test to diagnose paralyzing, blinding disease
10. First US SARS vaccine trial opens at NIH
11. First-ever safety study of medical cannabis use in Canada launched

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Walking Bed Rest For First Stage Labor Southwestern Research Shows

(Date:7/30/2014)... 2014. A new network of 25 regional stroke centers ... (NIH StrokeNet) is working to change the way ... advances of the last two decades, stroke remains a ... or disability for 795,000 Americans. The numbers are expected ... , To accelerate the pace of progress, NIH ...
(Date:7/30/2014)... OR (PRWEB) July 30, 2014 LTC Consumer, ... evaluate long term care insurance, features an Instant Quote tool ... Director and co-founder of LTC Consumer. Quotes are free and ... a click in only seven areas – including age, gender, ... on screen within seconds (you don’t need to enter any ...
(Date:7/30/2014)... The Institute for Integrative Nutrition (IIN), ... Arianna Huffington has joined as a guest speaker and is ... Training Program . , Arianna Huffington is the chair, president, ... blogging site that won a Pulitzer Prize in 2012 for ... was included on the Forbes “Most Powerful Women” list of ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- For patients with ... enough to trigger airway inflammation for at least 24 ... what you smell, but also what you think you ... Chemical Senses Center in Philadelphia, said in a Monell ... scents and fragrances. When we expect that an odor ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 According ... and Machine Vision Market by Technology (ICS, MES, ... Embedded), Components (Camera, FGOL), Application (Process, Discrete) - ... published by MarketsandMarkets, the Mexican market is expected ... 6.18% by 2020. , Browse 70 market data ...
Breaking Medicine News(10 mins):Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 4
(Date:7/30/2014)... 30, 2014   Epic Sciences, Inc. ... and develops novel diagnostics to personalize and advance ... the completion of a $30 million Series C ... RusnanoMedInvest (RMI) and Arcus Ventures, existing investors Domain ... as well as undisclosed individual investors. With the ...
(Date:7/30/2014)... 2014 Die Apex Medical Corporation ... Bereich Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass ... Deutschland anfechten werden. Dieses hat entschieden, dass ... von ResMed verletze. Apex weist darauf hin, ... verschiedene Patente von ResMed Anfechtungen wegen Nichtigkeit ...
(Date:7/29/2014)... Amgen (NASDAQ: AMGN ) today announced financial ... include: , Total revenues increased 11 percent to ... by strong performance across the portfolio, particularly Enbrel ® ... (denosumab) and XGEVA ® (denosumab). , Adjusted ... revenues and a significant increase in the profitability of ...
Breaking Medicine Technology:Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25
Cached News: